New oral anticoagulants in patients with chronic kidney disease.

New oral anticoagulants in patients with chronic kidney disease. Nefrologia. 2016 Dec 08;: Authors: Belmar Vega L, de Francisco AL, Bada da Silva J, Galván Espinoza L, Fernández Fresnedo G Abstract Patients with chronic kidney disease (CKD) develop bleeding and thrombotic tendencies, so the indication of anticoagulation at the onset of atrial fibrillation (AF) is complex. AF is the most common chronic cardiac arrhythmia, and thromboembolism and ischemic stroke in particular are major complications. In recent years, new oral anticoagulant drugs have been developed, and they have shown superiority over the classical AVK in preventing stroke, systemic embolism and bleeding risk, constituting an effective alternative to those resources. PMID: 27939514 [PubMed - as supplied by publisher]
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - Category: Urology & Nephrology Tags: Nefrologia Source Type: research